4 completed, 1 active not recruiting, 1 terminated. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow Corticosteroids (CS): new trials by email Literature Review of Corticosteroids (CS) trials Research Report on Corticosteroids (CS)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Concomitant Use of Steroids and Immune-Checkpoint Inhibitors on Survival Outcomes in NSCLC Patients Corticosteroids (CS), Immune Checkpoint Inhibitors - NSCLC, Non Small Cell Lung Cancer | Active not recruiting | Seoul National University | 2000 | 2024-11-01 | 2024-12-27 | |
| Immunophenotyping Profiling in Patients With Primary Nephrotic Syndrome Rituximab (MABTHERA® or RITUXAN®)., Corticosteroids (CS) - Membranous Nephropathy, Minimal Change Disease (MCD) | Completed | University Hospital, Ioannina | 40 | 2023-06-01 | 2026-07-14 | |
| A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation TCD601, Tacrolimus (TAC), Corticosteroids (CS) - Kidney Transplantation | Phase 2 | Terminated | ITB-Med LLC | 33 | 2021-06-06 | 2026-03-12 |
| A Dose Escalation Study in de Novo Renal Transplantation TCD601, Tacrolimus (TAC), Corticosteroids (CS) - Kidney Transplantation | Phase 2 | Completed | ITB-Med LLC | 13 | 2021-05-26 | 2025-02-27 |
| Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients CFZ533 - Cohort 1/Cohort 2, Mycophenolate Mofetil (MMF), Corticosteroids (CS) - Kidney Transplantation | Phase 2 | Completed | Novartis Pharmaceuticals | 418 | 2018-11-28 | 2026-03-23 |
| CCFZ533X2201 - PoC Study in de Novo Renal Transplantation CFZ533, Tacrolimus (Tac), Mycophenolate mofetil (MMF) - Kidney Transplantation | Phase 1 / Phase 2 | Completed | Novartis Pharmaceuticals | 59 | 2015-02-05 | 2021-09-28 |
Carcinoma, Non-Small-Cell Lung (1) · Glomerulonephritis, Membranous (1) · Glomerulosclerosis, Focal Segmental (1) · Macular dystrophy, corneal type 1 (1) · Nephrosis, Lipoid (1) · Nephrotic Syndrome (1)
ITB-Med LLC (2) · Novartis Pharmaceuticals (2) · Seoul National University (1) · University Hospital, Ioannina (1)
United States (3) · Brazil (2) · Germany (2) · Netherlands (2) · South Korea (2) · Spain (2) · Sweden (2) · Argentina (1) · Australia (1) · Austria (1) · Belgium (1) · Canada (1) · Czechia (1) · France (1) · Greece (1)
Evangelia Dounousi, Medical Degree (1) · Fredrik Juhlin (1) · Nick Hryciw, MA (1)
2017 (1)